Immune-modifying nanoparticles for the treatment of inflammatory diseases
US9913883B2 · kind B2 · utility
6Cited by
0References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Mar 13, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The current invention involves the administration of negatively charged particles, such as polystyrene, PLGA, or diamond particles, to subjects to ameliorate inflammatory immune responses. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same negatively charged particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.